01 4Theratechnologies Inc.
01 22222068
02 22485472
01 4TESAMORELIN ACETATE
01 2POWDER
02 2POWDER FOR SOLUTION
01 22016-05-22
02 22024-10-20
Patent Expiration Date : 2024-10-20
Date Granted : 2011-09-27
Brand Name : EGRIFTA
Patent Number : 2485472
Filing Date : 2004-10-20
Strength per Unit : 2 mg / vial
Dosage Form : POWDER
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2024-10-20
Date Granted : 2011-09-27
Patent Expiration Date : 2016-05-22
Date Granted : 2007-04-10
Brand Name : EGRIFTA
Patent Number : 2222068
Filing Date : 1996-05-22
Strength per Unit : 2 mg / vial
Dosage Form : POWDER
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2016-05-22
Date Granted : 2007-04-10
Patent Expiration Date : 2024-10-20
Date Granted : 2011-09-27
Brand Name : EGRIFTA
Patent Number : 2485472
Filing Date : 2004-10-20
Strength per Unit : 1 mg per vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2024-10-20
Date Granted : 2011-09-27
Patent Expiration Date : 2016-05-22
Date Granted : 2007-04-10
Brand Name : EGRIFTA
Patent Number : 2222068
Filing Date : 1996-05-22
Strength per Unit : 1 mg per vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2016-05-22
Date Granted : 2007-04-10
